A new Alzheimer’s treatment from US firm Eli Lilly was approved for use this week by the UK drug regulator MHRA, although disappointingly for its maker, the drug won’t be available on the NHS as it ...

350 mg/20 mL every four weeks injection for IV infusion), Eli Lilly and Company's (NYSE: LLY) Alzheimer's treatment for adults with early symptomatic Alzheimer's disease (AD), which includes ...

Lina Polimeni, chief corporate brand officer at Lilly, notes that public perception of the company has historically been ...

Global Gene Therapy in CNS Disorder IndustryThe global gene therapy market for central nervous system (CNS) disorders is set ...

Moving ahead, Rob Rowe, Regional Research Director and Head of Global Strategy at a large US bank is ‘ tactically bullish ’ on the back of continuing tech recovery and the markets “pricing in a soft ...

Citi raised the firm’s price target on Eli Lilly (LLY) to $1,250 from $1,060 and keeps a Buy rating on the shares following a transfer of ...

New results show Eli Lilly’s Ebglyss improved skin and itch among patients with moderate-to-severe atopic dermatitis who were previously treated with dupilumab. These results fr ...

As more Big Pharma companies have launched direct-to-consumer telehealth platforms, lawmakers have raised concerns they might ...

With both candidates in Texas, Trump takes aim at his rival's immigration policy while Harris pledges to codify the right to abortion. Brothers Lyle and Erik Menendez are serving jail sentences ...

Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., October 23, 2024. REUTERS/Brendan McDermid/File Photo The Nasdaq ended higher on Friday, driven by megacap ...

Prime Minister Narendra Modi today said this is the right time to join India's growth story, as German Chancellor Olaf Scholz met the Prime Minister in the national capital with a business delegation.

Alzheimer’s causes a gradual decline in memory, thinking, behaviour, and social skills, and it is the most common cause of ...